Scientists searching for cures to cancer, diabetes, Alzheimer's, and other deadly illnesses may soon lose their funding, due to a misguided proposal from Secretary of Health and Human Services Alex Azar.
The proposal would gradually reduce Medicare's reimbursement rate for advanced drugs administered in hospitals and doctor's offices by 30 percent. Sec. Azar claims these price controls "will save $17 billion in Medicare drug spending over the next five years."